Latest Survival news
N-AVD Yields High Progression-Free Survival in Teens With Hodgkin Lymphoma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer
posted January 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Circulating Tumor DNA Linked to Poor Prognosis in HER2-Positive Early Breast Cancer
posted January 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum 
Lung Transplant Can Prolong Survival in Stage IV NSCLC Monthly Specialist Briefings
Stay Connected
